MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
17.99
-0.04 (-0.22%)
Apr 25, 2025, 4:00 PM EDT - Market closed
MediWound Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MediWound stock have an average target of 32, with a low estimate of 25 and a high estimate of 39. The average target predicts an increase of 77.88% from the current stock price of 17.99.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 20, 2025.
Analyst Ratings
The average analyst rating for MediWound stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +38.97% | Mar 20, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +116.79% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +38.97% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +38.97% | Nov 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +55.64% | Oct 11, 2024 |
Financial Forecast
Revenue This Year
24.84M
from 20.22M
Increased by 22.84%
Revenue Next Year
31.42M
from 24.84M
Increased by 26.47%
EPS This Year
-2.90
from -3.03
EPS Next Year
-2.36
from -2.90
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.2M | 35.1M | 50.6M | ||
| Avg | 24.8M | 31.4M | 41.2M | ||
| Low | 23.0M | 27.9M | 34.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 34.4% | 41.4% | 61.0% | ||
| Avg | 22.8% | 26.5% | 31.0% | ||
| Low | 13.9% | 12.4% | 9.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.78 | -2.08 | -1.22 | ||
| Avg | -2.90 | -2.36 | -1.64 | ||
| Low | -2.90 | -2.73 | -2.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.